|
HIV Pharmacy Specialty Residency
A joint program of the University
Health Network and McGill University Health Centre
The Immunodeficiency Clinic, University Health Network in
Toronto, and Immunodeficiency Service, McGill University
Health Centre in Montreal, are 2 of the largest, university-affiliated,
outpatient HIV clinics in Canada, serving together over 2500
patients per year. Primary and specialty care is provided
through a comprehensive interdisciplinary approach (including
medicine, pharmacy, nursing, social work, nutrition, and
psychology). Other priorities include clinical research,
outreach programs, and antiretroviral therapeutic drug monitoring.
This 12-month program will provide the resident with experience
in a variety of HIV clinical settings, with a focus on ambulatory
care (other rotations include inpatient services, community
pharmacy, family practice clinics, drug information/marketing,
pediatrics, therapeutic drug monitoring, consulting, community
AIDS groups, and infectious diseases). The resident will
be expected to initiate and complete a research project.
The resident will also have teaching responsibilities for
B.Sc.Phm. / M.Sc. hospital residents and Pharm.D. candidates
doing elective HIV ambulatory rotations.
The primary preceptors
are Alice Tseng, Pharm.D., University Health Network, Assistant
Professor, Faculty of Pharmacy,
University of Toronto, and Nancy Sheehan, B.Pharm, M.Sc.,
McGill University Health Centre, Assistant Clinical Professor,
Faculty of Pharmacy, University of Montréal.
Applicants should possess a Pharm.D. or M.Sc.Phm. degree
(or equivalent experience) and have completed a CSHP- or
ASHP-accredited (PGY1) residency program. The desired starting
date is July-August of each year.
The option to complete a 2 year combined Residency/Master`s
program is also available. Upon completion of this program,
the resident will be awarded both a Specialty Residency Certificate
and a M.Sc.Phm. degree from the University of Toronto.
The annual stipend for the resident is $40 000 Canadian.
Funding for the HIV Pharmacy Specialty Residency has been
provided through an unrestricted educational grant from GlaxoSmithKline,
Pfizer Canada, Abbott Laboratories and Tibotec.
Interested applicants should send a cover letter describing
their interest, a curriculum vitae, and two letters of reference
before April 18th 2008 to both:
Patricia Marr, BScPharm, Pharm.D.
Immunodeficiency Clinic
Toronto General Hospital, 13N-1314
585 University Avenue
Toronto, Ontario, M5G 2N2
phone: (416) 340-4800, ext. 8763
fax: (416) 340-4890
e-mail: Patricia.Marr@uhn.on.ca |
Nancy Sheehan, B.Pharm, M.Sc.
Immunodeficiency Service, Montréal Chest Institute
McGill University Health Centre
3650 rue St-Urbain, 8th floor
Montréal, Québec H2X 2P4
Phone: 514-343-6111, ext 0884
Fax: 514-843-2828
e-mail: nancy.sheehan@muhc.mcgill.ca
|
Additional information:
HIV Residency Program Manual (new!)
Tseng A, Foisy M, Bajcar J, Musing E, Wells J, Grondin M, Salit I. Development of an HIV pharmacy practice specialty residency. Am J Health-Syst Pharm 2001;58:591-4.
HIV residency.ajhp01.pdf
Tseng A, Foisy M, Bajcar J, Musing E, Wells J, Grondin M, Salit I. Development of an HIV specialty pharmacy residency program [abstract WePpD1327]. Presented at the 13th International AIDS Conference,
Durban, South Africa. July 9-14, 2000. poster: hiv residency.durban00.pdf
|
